Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
Study to Characterize Atrial Fibrillation in CHF Patients Indicated for CRT
PIE II: Pharmacological Intervention in the Elderly II
Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
† Indicates status has not been verified in more than two years